active ingredients
Homosalate (10.0%), Octinoxate (7.5%), Octisalate (5.0%), Octocrylene (10.0%), Oxybenzone (5.0%).
Homosalate (10.0%), Octinoxate (7.5%), Octisalate (5.0%), Octocrylene (10.0%), Oxybenzone (5.0%).
Isododecane, Dicaprylyl Ether, Cyclopentasiloxane, Cocoglycerides, Butyloctyl Salicylate, Brassica Campestris/Aleurites Fordi Oil Copolymer, Diisopropyl Adipate, Melissa Officinalis Leaf Extract, Citrus Grandis (Grapefruit) Peel Oil, Retinyl Palmitate, Ascorbyl Palmitate, Limonene, Tocopheryl Acetate, Caprylyl Glycol.
For external use only, not to be swallowed. Avoid contact with eyes. If contact occurs, flush thoroughly with water.
If irritation develops, discontinue use.
Do not use on infants under 6 months old.
Dermalogica, Dist.
Los Angeles, CA 90009 USA
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 21839-091-25 | 2019-11-13 | C162847 | 48780-1 | 97449f38-cab5-f6ea-e053-dbdaa90aa703 | Dermalogica ® waterblock solar spray spf 30 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 21839-091-25 | Waterblock Solar SPF 30 | 1 in 1 BOX | LIQUID | 1 | 1 | |
| 21839-091-25 | Waterblock Solar SPF 30 | 125 mL in 1 BOTTLE, PLASTIC | LIQUID | 125 | 1 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| Homosalate | ACTIVE INGREDIENT | V06SV4M95S | 1 | |
| Octinoxate | ACTIVE INGREDIENT | 4Y5P7MUD51 | 1 | |
| Octisalate | ACTIVE INGREDIENT | 4X49Y0596W | 1 | |
| Octocrylene | ACTIVE INGREDIENT | 5A68WGF6WM | 1 | |
| Oxybenzone | ACTIVE INGREDIENT | 95OOS7VE0Y | 1 | |
| Homosalate | ACTIVE MOIETY | V06SV4M95S | 1 | |
| Octinoxate | ACTIVE MOIETY | 4Y5P7MUD51 | 1 | |
| Octisalate | ACTIVE MOIETY | 4X49Y0596W | 1 | |
| Octocrylene | ACTIVE MOIETY | 5A68WGF6WM | 1 | |
| Oxybenzone | ACTIVE MOIETY | 95OOS7VE0Y | 1 | |
| Alpha-Tocopherol Acetate | INACTIVE INGREDIENT | 9E8X80D2L0 | 1 | |
| Ascorbyl Palmitate | INACTIVE INGREDIENT | QN83US2B0N | 1 | |
| Butyloctyl Salicylate | INACTIVE INGREDIENT | 2EH13UN8D3 | 1 | |
| Caprylyl Glycol | INACTIVE INGREDIENT | 00YIU5438U | 1 | |
| Citrus Maxima Fruit Rind Oil | INACTIVE INGREDIENT | 8U3877WD44 | 1 | |
| Coco-glycerides | INACTIVE INGREDIENT | ISE9I7DNUG | 1 | |
| Cyclomethicone 5 | INACTIVE INGREDIENT | 0THT5PCI0R | 1 | |
| Dicaprylyl Ether | INACTIVE INGREDIENT | 77JZM5516Z | 1 | |
| Diisopropyl Adipate | INACTIVE INGREDIENT | P7E6YFV72X | 1 | |
| Isododecane | INACTIVE INGREDIENT | A8289P68Y2 | 1 | |
| Melissa Officinalis Leaf | INACTIVE INGREDIENT | 50D2ZE9219 | 1 | |
| Vitamin A Palmitate | INACTIVE INGREDIENT | 1D1K0N0VVC | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 21839-091 | 21839-091-25 |
Every source-derived ingredient row is available through these pages.
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| Diisopropyl Adipate | DIISOPROPYL ADIPATE | P7E6YFV72X | SPRAY / TOPICAL | 360 mg | ||
| Diisopropyl Adipate | DIISOPROPYL ADIPATE | P7E6YFV72X | GEL / TOPICAL | 150 mg | ||
| Alpha-Tocopherol Acetate | .ALPHA.-TOCOPHEROL ACETATE | 9E8X80D2L0 | CAPSULE / ORAL | 2 mg | ||
| Ascorbyl Palmitate | ASCORBYL PALMITATE | QN83US2B0N | SOLUTION / TOPICAL | NA | ||
| Cyclomethicone 5 | CYCLOMETHICONE 5 | 0THT5PCI0R | CREAM, AUGMENTED / TOPICAL | 260 mg | ||
| Ascorbyl Palmitate | ASCORBYL PALMITATE | QN83US2B0N | CAPSULE / ORAL | 12 mg | ||
| Cyclomethicone 5 | CYCLOMETHICONE 5 | 0THT5PCI0R | AEROSOL, FOAM / TOPICAL | 144 mg | ||
| Diisopropyl Adipate | DIISOPROPYL ADIPATE | P7E6YFV72X | LOTION / TOPICAL | 250 mg | ||
| Alpha-Tocopherol Acetate | .ALPHA.-TOCOPHEROL ACETATE | 9E8X80D2L0 | FILM / BUCCAL | 0.09 mg | ||
| Ascorbyl Palmitate | ASCORBYL PALMITATE | QN83US2B0N | CREAM / TOPICAL | 0.02 %w/w | ||
| Diisopropyl Adipate | DIISOPROPYL ADIPATE | P7E6YFV72X | SOLUTION / TOPICAL | 815 mg | ||
| Ascorbyl Palmitate | ASCORBYL PALMITATE | QN83US2B0N | SYSTEM / TOPICAL | 0.04 mg | ||
| Diisopropyl Adipate | DIISOPROPYL ADIPATE | P7E6YFV72X | AEROSOL, FOAM / TOPICAL | 200 mg | ||
| Diisopropyl Adipate | DIISOPROPYL ADIPATE | P7E6YFV72X | GEL / TRANSDERMAL | 1.5 %w/w | ||
| Ascorbyl Palmitate | ASCORBYL PALMITATE | QN83US2B0N | TABLET / ORAL | 7.14 mg | ||
| Ascorbyl Palmitate | ASCORBYL PALMITATE | QN83US2B0N | SUPPOSITORY / RECTAL | 16 mg | ||
| Cyclomethicone 5 | CYCLOMETHICONE 5 | 0THT5PCI0R | AEROSOL / TOPICAL | 2.5 %w/w | ||
| Alpha-Tocopherol Acetate | .ALPHA.-TOCOPHEROL ACETATE | 9E8X80D2L0 | TABLET / ORAL | 0.5 mg | ||
| Diisopropyl Adipate | DIISOPROPYL ADIPATE | P7E6YFV72X | CREAM / TOPICAL | 170 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 6f3d5cc8-cae0-47e5-be32-356236a5613f | 6f06c25e-350b-4a3c-b034-7db00541e03a | 2011-10-26 | Warnings | 6f3d5cc8-cae0-47e5-be32-356236a5613f 6f06c25e-350b-4a3c-b034-7db00541e03a |
Adverse event summaries are temporarily unavailable. Other product information remains available.